Drug Shortage Report for BURINEX
| Report ID | 185280 |
| Drug Identification Number | 00728276 |
| Brand name | BURINEX |
| Common or Proper name | BURINEX TAB 5 MG |
| Company Name | KARO PHARMA AB |
| Market Status | MARKETED |
| Active Ingredient(s) | BUMETANIDE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| Anatomical Therapeutical Chemical (ATC) code | C03CA |
| Anatomical Therapeutical Chemical (ATC) description | HIGH-CEILING DIURETICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-12-05 |
| Estimated end date | |
| Actual end date | 2023-04-23 |
| Shortage status | Resolved |
| Updated date | 2023-04-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | KLARA NORRA KYRKOGATA 33 STOCKHOLM, -- SWEDEN 11122 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-04-24 | French | Compare |
| v5 | 2023-04-03 | French | Compare |
| v4 | 2023-04-03 | English | Compare |
| v3 | 2023-02-22 | French | Compare |
| v2 | 2023-02-22 | English | Compare |
| v1 | 2023-02-22 | English | Compare |
Showing 1 to 6 of 6